Urological research, Malmö

91 – 100 of 183

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000568?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
9
10
11
12
…
19
next »

2010
Mark Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
Marschner, Norbert ; Ruettinger, Dominik ; Zugmaier, Gerhard ; Nemere, Gyula ; Lehmann, Jan ; Obrist, Peter ; Baeuerle, Patrick A. ; Wolf, Andreas ; Schmidt, Margit and Abrahamsson, Per-Anders ^LU , et al. (2010) In Urologia Internationalis 85(4). p.386-395
- Contribution to journal › Article
Mark HIF1 alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation
Monsef, Nastaran ^LU ; Soller, Maria ^LU ; Panagopoulos, Ioannis ^LU and Abrahamsson, Per-Anders ^LU (2010) In BMC Cancer 10.
- Contribution to journal › Article
Mark Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature.
Abrahamsson, Per-Anders ^LU (2010) In European Urology 57. p.49-59
- Contribution to journal › Article
Mark Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model.
Cervin, Camilla ; Tinzl, Martina ^LU ; Johnsson, Markus ; Abrahamsson, Per-Anders ^LU ; Tiberg, Fredrik and Dizeyi, Nishtman ^LU (2010) In European Journal of Pharmaceutical Sciences 41. p.369-375
- Contribution to journal › Article
Mark Reply to Tomasz Drewa's Letter to the Editor re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49-59.
Abrahamsson, Per-Anders ^LU and Ceder, Jens ^LU (2010) In European Urology Mar 4. p.5-6
- Contribution to journal › Letter
Mark PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population.
Nyberg, Martin ; Ulmert, David ^LU ; Lindgren, Anna ^LU ; Lindström, Ulla ^LU ; Abrahamsson, Per-Anders ^LU and Bjartell, Anders ^LU (2010) In Scandinavian Journal of Urology and Nephrology 44. p.378-383
- Contribution to journal › Article
Mark Label retaining cells and stem cell marker expression in the developing and adult mouse prostate
Ceder, Jens ^LU ; Aalders, T. ; Jansen, K. ; Abrahamsson, Per-Anders ^LU and Schalken, J. A. (2010) In Differentiation 80. p.39-39
- Contribution to journal › Published meeting abstract
Mark Identification of urothelial stem cells for tissue engineering
Sun, W. ; Ceder, Jens ^LU ; Geutjes, P. J. ; Schalken, J. A. and Oosterwijk, E. (2010) In Differentiation 80. p.46-46
- Contribution to journal › Published meeting abstract
2009
Mark Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
Saad, Fred ; Abrahamsson, Per-Anders ^LU and Miller, Kurt (2009) In BJU International 104(11). p.1573-1579
- Contribution to journal › Scientific review
Mark COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT
Damber, J. E. ; Tammela, T. ; Abrahamsson, Per-Anders ^LU ; Iversen, P. ; Jensen, J. K. ; Olesen, T. K. and Persson, B-E (2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.130-130
- Contribution to journal › Published meeting abstract

« previous
1
…
9
10
11
12
…
19
next »